These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1209 related items for PubMed ID: 6165731
1. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K. J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731 [Abstract] [Full Text] [Related]
2. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis. Yoshida K, Sakurada T, Kaise N, Kaise K, Kitaoka H, Fukazawa H, Yamamoto M, Saito S, Yoshinaga K. J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591 [Abstract] [Full Text] [Related]
3. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis. Izumi Y, Hidaka Y, Tada H, Takano T, Kashiwai T, Tatsumi KI, Ichihara K, Amino N. Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069 [Abstract] [Full Text] [Related]
4. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. Jaffiol C, Baldet L, Robin M, Papachristou C, Lapinski H, Mirouze J. Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177 [Abstract] [Full Text] [Related]
5. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease. Amino N, Yabu Y, Miyai K, Fujie T, Azukizawa M, Onishi T, Kumahara Y. Lancet; 1978 Aug 12; 2(8085):344-6. PubMed ID: 79711 [Abstract] [Full Text] [Related]
6. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T, Urabe K, Tanaka T, Yoshida A, Mashiba H. J Clin Endocrinol Metab; 1987 Aug 12; 65(2):359-63. PubMed ID: 3110204 [Abstract] [Full Text] [Related]
7. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, Amino N. Endocr J; 2005 Oct 12; 52(5):537-42. PubMed ID: 16284430 [Abstract] [Full Text] [Related]
8. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR. J Clin Endocrinol Metab; 1975 Dec 12; 41(06):1098-104. PubMed ID: 54364 [Abstract] [Full Text] [Related]
10. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. Takamatsu J, Kuma K, Mozai T. J Clin Endocrinol Metab; 1986 May 12; 62(5):980-3. PubMed ID: 3754263 [Abstract] [Full Text] [Related]
11. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y, Miyai K. J Clin Endocrinol Metab; 1982 Jul 12; 55(1):108-12. PubMed ID: 6896207 [Abstract] [Full Text] [Related]
12. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T. J Clin Endocrinol Metab; 1988 Jan 12; 66(1):147-52. PubMed ID: 3335601 [Abstract] [Full Text] [Related]
13. Transient recurrence of hyperthyroidism after delivery in Graves' disease. Amino N, Miyai K, Yamamoto T, Kuro R, Tanaka F. J Clin Endocrinol Metab; 1977 Jan 12; 44(1):130-6. PubMed ID: 576228 [Abstract] [Full Text] [Related]
14. A case of total thyroxine-binding globulin deficiency with Graves' disease: fluctuations of plasma triiodothyronine/thyroxine ratio. Kamikubo K, Kojima N, Yamakita N, Miura K. Jpn J Med; 1986 May 12; 25(2):186-90. PubMed ID: 3091890 [Abstract] [Full Text] [Related]
15. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y. J Clin Endocrinol Metab; 1995 Jul 12; 80(7):2173-7. PubMed ID: 7608274 [Abstract] [Full Text] [Related]
16. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Mori H, Amino N, Iwatani Y, Asari S, Izumiguchi Y, Kumahara Y, Miyai K. J Clin Endocrinol Metab; 1982 Sep 12; 55(3):399-402. PubMed ID: 6178751 [Abstract] [Full Text] [Related]
17. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. Takamatsu J, Sugawara M, Kuma K, Kobayashi A, Matsuzuka F, Mozai T, Hershman JM. Ann Intern Med; 1984 Mar 12; 100(3):372-5. PubMed ID: 6546484 [Abstract] [Full Text] [Related]
18. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. J Clin Endocrinol Metab; 1975 Nov 12; 41(5):911-20. PubMed ID: 1242390 [Abstract] [Full Text] [Related]
19. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P. Eur J Endocrinol; 2013 Nov 12; 169(5):537-45. PubMed ID: 23935127 [Abstract] [Full Text] [Related]
20. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. Nicoloff JT, Low JC, Dussault JH, Fisher DA. J Clin Invest; 1972 Mar 12; 51(3):473-83. PubMed ID: 4110897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]